Revance Therapeutics share price today
(RVNC)
Revance Therapeutics share price is $3.47 & ₹297.76 as on 7 Jan 2025, 2.30 'hrs' IST
$3.47
▲
0.38
(12.3%)
Market is closed - opens 8 PM, 07 Jan 2025
View live Revance Therapeutics share price in Dollar and Rupees. Guide to invest in Revance Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Revance Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Revance Therapeutics share price movements
- Today's Low: $3.46Today's High: $3.61
0.29%
Downside
Day's Volatility :4.02%
Upside
3.74%
- 52 Weeks Low: $2.3052 Weeks High: $8.72
33.72%
Downside
52 Weeks Volatility :73.62%
Upside
60.21%
Revance Therapeutics Returns
Revance Therapeutics Key Statistics
in dollars & INR
How to invest in Revance Therapeutics from India?
It is very easy for Indian residents to invest directly in Revance Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Revance Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Revance Therapeutics or RVNC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Revance Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Revance Therapeutics shares which would translate to 0.247 fractional shares of Revance Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Revance Therapeutics, in just a few clicks!
Returns in Revance Therapeutics for Indian investors in Rupees
Investment Value
₹1,00,000
Revance Therapeutics investment value today
Current value as on today
₹52,442
Returns
Returns from Revance Therapeutics Stock
Dollar Returns
₹3,223 (+3.22%)
Indian investors sentiment towards Revance Therapeutics
Global Institutional Holdings in Revance Therapeutics
BlackRock Inc
8.21%
Vanguard Group Inc
5.49%
Franklin Resources Inc
4.58%
Fidelity International Ltd
4.02%
Eckert Corp
3.99%
AllianceBernstein L.P.
3.12%
Analyst Recommendation on Revance Therapeutics
Buy
72%Buy
27%Hold
0%Sell
Based on 18 Wall street analysts offering stock ratings for Revance Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Revance Therapeutics
What analysts predicted
Upside of 120.09%
Current:
$3.47
Target:
$7.64
Insights on Revance Therapeutics
Price Movement
In the last 1 month, RVNC stock has moved down by -19.1%Decreasing Revenue
Revenue is down for the last 2 quarters, 65.38M → 59.87M (in $), with an average decrease of 8.4% per quarterIncreasing Net Profit
Netprofit is up for the last 5 quarters, -141.17M → -35.11M (in $), with an average increase of 51.7% per quarterRVNC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 86.7%RVNC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 135.0%Price to Sales
ForRVNC every $1 of sales, investors are willing to pay $1.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.
Revance Therapeutics Financials in INR & Dollars
Revance Therapeutics Technicals Summary
Sell
Neutral
Buy
Revance Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Revance Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 1.98% | 6.92% | -56.17% | -79.94% | -81.26% |
 | -8.86% | -31.87% | -20.46% | 15.59% | 87.28% |
 | -4.16% | 43.82% | 3.49% | -49.66% | 167.6% |
 | -8.45% | -8.03% | 19.03% | 56.02% | 98.44% |
 | -14.11% | -16.23% | -2.87% | 81.78% | 76.8% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | -0.64 | -1.64 | -20.97 | -0.24 | NA | -1.55 |
| 17.61 | 17.61 | 1.06 | 45.07 | 0.17 | 0.07 | NA | 272.04 |
| 160.8 | NA | 0.04 | -3.11 | -0.02 | -0.01 | NA | 79.73 |
| NA | NA | -0.49 | -0.19 | -15.01 | -0.03 | NA | 0.25 |
| 32.84 | NA | 1.06 | 0.51 | -0.03 | 0.12 | NA | 60.65 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $317.3M | -81.26% | NA | -71.78% |
| Buy | $78.3B | 87.28% | 17.61 | 33.61% |
| Buy | $27.3B | 167.6% | 160.8 | -15.36% |
| Buy | $30.4B | 98.44% | NA | -15.86% |
| Buy | $103.7B | 76.8% | 32.84 | -4.51% |
About Revance Therapeutics
Management People of Revance Therapeutics
Important FAQs about investing in Revance Therapeutics from India :
What is Revance Therapeutics share price today?
Revance Therapeutics share price today stands at $3.47, Open: $3.51 ; Previous Close: $3.09 ; High: $3.61 ; Low: $3.46 ; 52 Week High: $8.72 ; 52 Week Low: $2.30. The stock opens at $3.51, after a previous close of $3.09. The stock reached a daily high of $3.61 and a low of $3.46, with a 52-week high of $8.72 and a 52-week low of $2.30.
Can Indians buy Revance Therapeutics shares?
Yes, Indians can invest in the Revance Therapeutics (RVNC) from India.
With INDmoney, you can buy Revance Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Revance Therapeutics at zero transaction cost.
How can I buy Revance Therapeutics shares from India?
It is very easy to buy Revance Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Revance Therapeutics be purchased?
Yes, you can buy fractional shares of Revance Therapeutics with INDmoney app.
What are the documents required to start investing in Revance Therapeutics stocks?
To start investing in Revance Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Revance Therapeutics
Today’s highest price of Revance Therapeutics (RVNC) is $3.61.
Today’s lowest price of Revance Therapeutics (RVNC) is $3.46.
What is today's market capitalisation of Revance Therapeutics
What is the 52 Week High and Low Range of Revance Therapeutics
52 Week High
$8.72
52 Week Low
$2.30
What are the historical returns of Revance Therapeutics?
1 Month Returns
1.98%
3 Months Returns
6.92%
1 Year Returns
-56.17%
5 Years Returns
-81.26%
